Spontaneous Correction of Sagittal Imbalance After Isolated Lumbar Decompression

NCT ID: NCT07139938

Last Updated: 2025-12-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

165 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-06

Study Completion Date

2027-10-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sagittal spinal imbalance may be caused by orthopedic problems, compression of the neural structures of the spinal canal, and pain syndrome (functional imbalance). Sagittal imbalance in combination with appropriate clinical symptoms may require surgical correction of the spine with fixation. However, in some cases, patients experience spontaneous correction of sagittal balance after isolated decompression without any correction or fusion. Therefore, it is necessary to clarify whether isolated decompression may cause spontaneous correction of sagittal imbalance in patients with degenerative lumbar stenosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

LUMBAR STENOSIS Sagittal Imbalance Degeneration Lumbar Spine Lumbar Decompression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort

Isolated lumbar decompression

Group Type OTHER

Isolated lumbar decomression

Intervention Type PROCEDURE

All patients will undergo microsurgical decompression of stenosed neural structures of the lumbar canal at all clinically significant levels with saving the posterior spinal column (type of decompression may be as unilateral, bilateral, or bilateral from a unilateral approach (over-the-top)), including endoscopic decompression.

Degenerative lumbar stenosis may be caused by thickened yellow and posterior longitudinal ligaments, facet joints hypertrophy, vertebral body osteophytes posteriorly, synovial (facet joints cysts) and disc cysts.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Isolated lumbar decomression

All patients will undergo microsurgical decompression of stenosed neural structures of the lumbar canal at all clinically significant levels with saving the posterior spinal column (type of decompression may be as unilateral, bilateral, or bilateral from a unilateral approach (over-the-top)), including endoscopic decompression.

Degenerative lumbar stenosis may be caused by thickened yellow and posterior longitudinal ligaments, facet joints hypertrophy, vertebral body osteophytes posteriorly, synovial (facet joints cysts) and disc cysts.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. Age 45 and over;
* 2\. Radicular leg pain and/or neurogenic claudication with/without back pain, caused by single- or multi-level degenerative lumbar stenosis with/without spodylolisthesis, confirmed by MRI;
* 3\. Planned isolated decompression of the spinal canal without implantation of any devices;
* 4\. Symptoms persisting for at least 3 months prior to surgery;
* 5\. Given written Informed Consent;
* 6\. Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements.


* 1\. Prior any lumbar surgery;
* 2\. Scoliosis of any non-degenerative etiology (due to vertebral fractures, idiopathic, etc.);
* 3\. Degenerative scoliosis \> 20 degrees;
* 4\. Any contraindication or inability to undergo baseline and/or follow up MRI or X-ray as required per protocol;
* 5\. Any other condition or situation that the investigator believes may interfere with the safety of the subject or the intent and conduct of the study;

Exclusion Criteria

* 1\. Performed intraoperative discotomy;
* 2\. Performed intraoperative iatrogenic instability of the lumbar segment (facetectomy, foraminotomy, etc.)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Burdenko Neurosurgery Institute

OTHER

Sponsor Role collaborator

Pirogov National Medical Surgical Center

OTHER_GOV

Sponsor Role collaborator

N.N. Priorov National Medical Research Center of Traumatology and Orthopedics

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pirogov National Medical Surgical Center

Moscow, , Russia

Site Status RECRUITING

Burdenko Neurosurgery Institute

Moscow, , Russia

Site Status RECRUITING

Priorov National Medical Research Center of Traumatology and Orthopedics

Moscow, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Aleksandr Krutko, MD, PhD

Role: CONTACT

+7 495 744 40 11

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Aleksandr Krutko, MD, PhD

Role: primary

+7 495 744 40 11

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NS12-05

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.